"Although the story mentions the cost of immunosuppressant drugs, the story does not mention the cost of the new transplant technique. Given the preliminary nature of the findings, it is not yet possible to quantify the benefits of the new transplantation technique. The story does not mention any potential harms of the therapy. The story adequately describes the strength of the available evidence. The story describes the studies as ""preliminary"" and brings attention to the very small sample sizes. However, the story could have made less use of such terms as ""groundbreaking"" and ""breakthrough"" to describe the treatment in light of the preliminary nature of the findings. The story does not exaggerate the prevalence or seriousness of kidney disease. The story quotes multiple experts The story mentions immunosuppressants with traditional transplantation as the alternative to the new transplant technique. The story clearly states that the transplant technique is experimental and is only being performed in a handful of medical centers. The story clearly states that the treatment is a new approach. Because the story quotes multiple sources, the reader can assume that the story did not rely on a press release as the sole source of information."
Some transplant patients OK without years of drug treatment